[HTML][HTML] The impact of VEGF on cancer metastasis and systemic disease
Metastasis is the leading cause of cancer-associated mortality and the underlying
mechanisms of cancer metastasis remain elusive. Both blood and lymphatic vasculatures …
mechanisms of cancer metastasis remain elusive. Both blood and lymphatic vasculatures …
Vessel co-option in cancer
All solid tumours require a vascular supply in order to progress. Although the ability to
induce angiogenesis (new blood vessel growth) has long been regarded as essential to this …
induce angiogenesis (new blood vessel growth) has long been regarded as essential to this …
Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence
AB Chinen, CM Guan, JR Ferrer, SN Barnaby… - Chemical …, 2015 - ACS Publications
Cancer is the second most common cause of death in the United States, trailing only heart
disease in incidence. Despite significant worldwide investment in research, cancer remains …
disease in incidence. Despite significant worldwide investment in research, cancer remains …
[HTML][HTML] Mucinous colorectal adenocarcinoma: clinical pathology and treatment options
C Luo, S Cen, G Ding, W Wu - Cancer communications, 2019 - Springer
Mucinous colorectal adenocarcinoma is a distinct subtype of colorectal cancer (CRC)
characterized by the presence of abundant extracellular mucin which accounts for at least …
characterized by the presence of abundant extracellular mucin which accounts for at least …
Targeted cancer therapy: the next generation of cancer treatment
TA Baudino - Current drug discovery technologies, 2015 - ingentaconnect.com
Cancer is one of the leading causes of death in the United States along with heart disease.
The hallmark of cancer treatment has been conventional chemotherapy. Chemotherapeutic …
The hallmark of cancer treatment has been conventional chemotherapy. Chemotherapeutic …
VEGF targets the tumour cell
HL Goel, AM Mercurio - Nature Reviews Cancer, 2013 - nature.com
The function of vascular endothelial growth factor (VEGF) in cancer is not limited to
angiogenesis and vascular permeability. VEGF-mediated signalling occurs in tumour cells …
angiogenesis and vascular permeability. VEGF-mediated signalling occurs in tumour cells …
[HTML][HTML] Tumor angiogenesis: MMP-mediated induction of intravasation-and metastasis-sustaining neovasculature
EI Deryugina, JP Quigley - Matrix Biology, 2015 - Elsevier
Metastasis is a distinct stage of cancer progression that requires the development of
angiogenic blood vessels serving as conduits for tumor cell dissemination. An accumulated …
angiogenic blood vessels serving as conduits for tumor cell dissemination. An accumulated …
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin, LM Ellis - Journal of clinical oncology, 2005 - ascopubs.org
New blood vessel formation (angiogenesis) is a fundamental event in the process of tumor
growth and metastatic dissemination. Hence, the molecular basis of tumor angiogenesis has …
growth and metastatic dissemination. Hence, the molecular basis of tumor angiogenesis has …
[HTML][HTML] Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1
J Lu, X Ye, F Fan, L Xia, R Bhattacharya, S Bellister… - Cancer cell, 2013 - cell.com
We report a paracrine effect whereby endothelial cells (ECs) promote the cancer stem cell
(CSC) phenotype of human colorectal cancer (CRC) cells. We showed that, without direct …
(CSC) phenotype of human colorectal cancer (CRC) cells. We showed that, without direct …
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity
Suppression of dendritic cell function in cancer patients is thought to contribute to the
inhibition of immune responses and disease progression. Molecular mechanisms of this …
inhibition of immune responses and disease progression. Molecular mechanisms of this …